Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,026 | 1,723 | 3,196 | 4,945 | 6,623 |
| Marketable Securities | 98 | 227 | 154 | 88 | 193 |
| Receivables | 137 | 225 | 107 | 251 | 189 |
| Inventories | 2,636 | 2,641 | 2,651 | 3,748 | 3,750 |
| Other current assets | 220 | 262 | 358 | 322 | 444 |
| TOTAL | $6,117 | $5,078 | $6,466 | $9,354 | $11,199 |
| Non-Current Assets | |||||
| PPE Net | 7,947 | 8,104 | 8,213 | 8,309 | 8,470 |
| Intangibles | 1,181 | 1,179 | 1,170 | 1,022 | 952 |
| Other Non-Current Assets | 1,261 | 1,312 | 1,329 | 1,385 | 1,337 |
| TOTAL | $10,389 | $10,595 | $10,712 | $10,716 | $10,759 |
| Total Assets | $16,506 | $15,673 | $17,178 | $20,070 | $21,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 549 | 672 | 530 | 466 | 456 |
| Accrued Expenses | 1,557 | 1,459 | 1,368 | 890 | 926 |
| TOTAL | $2,106 | $2,131 | $1,898 | $1,356 | $1,382 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139 | 140 | 141 | 141 | 142 |
| Other Non-Current Liabilities | 163 | 200 | 228 | 256 | 290 |
| TOTAL | $302 | $340 | $369 | $397 | $432 |
| Total Liabilities | $2,408 | $2,471 | $2,267 | $1,753 | $1,814 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,734 | 53,917 | 53,077 | 53,077 | 53,067 |
| Common Shares | 122,732 | 119,322 | 118,965 | 118,382 | 117,899 |
| Retained earnings | -105,191 | -102,740 | -100,665 | -96,635 | -94,386 |
| Other shareholders' equity | -3,443 | -3,380 | -3,389 | -3,430 | -3,369 |
| TOTAL | $14,098 | $13,202 | $14,911 | $18,317 | $20,144 |
| Total Liabilities And Equity | $16,506 | $15,673 | $17,178 | $20,070 | $21,958 |